Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

DNDN has found great support between 20.50 and 21.50.

|Includes: Dendreon Corporation (DNDN)

Any FDA or company announcement regarding its phase three clinical trials will send its shares to the recent highs of 27 or beyond.